aTyr Pharma, Inc. Common Stock (ATYR) is a publicly traded Healthcare sector company. As of July 15, 2026, ATYR trades at $0.50 with a market cap of $49.43M and a P/E ratio of -0.63. ATYR moved +2.47% today. Year to date, ATYR is -37.94%; over the trailing twelve months it is -91.21%. Its 52-week range spans $0.40 to $7.29. Analyst consensus is buy with an average price target of $3.13. Rallies surfaces ATYR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
aTyr Pharma, Inc. Common Stock (ATYR) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. ATYR moved +2.47% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $0.50 |
| Market Cap | $49.43M |
| P/E Ratio | -0.63 |
| EPS | $-0.80 |
| Dividend Yield | 0.00% |
| 52-Week High | $7.29 |
| 52-Week Low | $0.40 |
| Volume | 877 |
| Avg Volume | 0 |
| Revenue (TTM) | $190.00K |
| Net Income | $-74.12M |
| Gross Margin | 0.00% |
6 analysts cover ATYR: 0 strong buy, 2 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $3.13.